Intentional Stent Stenosis to Prevent Hyperperfusion Syndrome after Carotid Artery Stenting for Extremely High-Grade Stenosis

References

1. 1.↵
   1. Mori T,
   2. Fukuoka M,
   3. Kazita K, et al

   . Intraventricular hemorrhage after carotid stenting. J Endovasc Surg 1999;6:337–41 doi:10.1583/1074-6218(1999)006<0337:IHACS>2.0.CO;2 pmid:10893135

   CrossRefPubMedWeb of Science
2. 2.
   1. Abou-Chebl A,
   2. Yadav JS,
   3. Reginelli JP, et al

   . Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol 2004;43:1596–601 doi:10.1016/j.jacc.2003.12.039 pmid:15120817

   FREE Full Text
3. 3.↵
   1. Sundt TM Jr.,
   2. Sharbrough FW,
   3. Piepgras DG, et al

   . Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc 1981;56:533–43 pmid:7266064

   PubMedWeb of Science
4. 4.↵
   1. Piepgras DG,
   2. Morgan MK,
   3. Sundt TM Jr., et al

   . Intracerebral hemorrhage after carotid endarterectomy. J Neurosurg 1988;68:532–36 doi:10.3171/jns.1988.68.4.0532 pmid:3351580

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Nomura JI,
   2. Uwano I,
   3. Sasaki M, et al

   . Preoperative cerebral oxygen extraction fraction imaging generated from 7T MR quantitative susceptibility mapping predicts development of cerebral hyperperfusion following carotid endarterectomy. AJNR Am J Neuroradiol 2017;38:2327–33 doi:10.3174/ajnr.A5390 pmid:28982786

   Abstract/FREE Full Text
6. 6.↵
   1. Hayakawa M,
   2. Matsumaru Y,
   3. Sakai N, et al

   ; for the STrategy of Optimal carotid revascularization for high-risk Patients of Cerebral Hyperperfusion Syndrome (STOP CHS) study group. Periprocedural evaluation and management against cerebral hyperperfusion syndrome after carotid artery stenting in Japan: a nationwide questionnaire survey. Journal of Neuroendovascular Therapy 2017;11:341–50 doi:10.5797/jnet.oa.2017-0009

   CrossRef
7. 7.↵
   1. Greene NH,
   2. Minhaj MM,
   3. Zaky AF, et al

   . Perioperative management of carotid endarterectomy: a survey of clinicians’ backgrounds and practices. J Cardiothorac Vasc Anesth 2014;28:990–93 doi:10.1053/j.jvca.2013.11.007 pmid:24594111

   CrossRefPubMed
8. 8.↵
   1. Kuroda H,
   2. Ogasawara K,
   3. Hirooka R, et al

   . Prediction of cerebral hyperperfusion after carotid endarterectomy using middle cerebral artery signal intensity in preoperative single-slab 3-dimensional time-of-flight magnetic resonance angiography. Neurosurgery 2009;64:1065–71; discussion 1071–72 doi:10.1227/01.NEU.0000345941.99443.99 pmid:19487885

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Ogasawara K,
   2. Sakai N,
   3. Kuroiwa T, et al

   ; Japanese Society for Treatment at Neck in Cerebrovascular Disease Study Group. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients. J Neurosurg 2007;107:1130–36 doi:10.3171/JNS-07/12/1130 pmid:18077950

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Niimi J,
    2. Tasaka K,
    3. Nemoto F, et al

    . A patient with stenosis of the cervical internal carotid artery in whom hyperperfusion syndrome occurred after staged angioplasty. Journal of Neuroendovascular Therapy 2017;11:634–39 doi:10.5797/jnet.cr.2017-0043

    CrossRef
11. 11.↵
    1. Yoshimoto T,
    2. Shirasaka T,
    3. Yoshidumi T, et al

    . Stepwise revascularization for prevention of postoperative hyperperfusion. Neurol Med Chir (Tokyo) 2006;46:283–87; discussion 288–89 doi:10.2176/nmc.46.283 pmid:16794348

    CrossRefPubMed
12. 12.↵
    1. Yoshimura S,
    2. Kitajima H,
    3. Enomoto Y, et al

    . Staged angioplasty for carotid artery stenosis to prevent postoperative hyperperfusion. Neurosurgery 2009;64:ons122–28; discussion ons128–29 doi:10.1227/01.NEU.0000334046.41985.BB pmid:19240561

    CrossRefPubMed
13. 13.↵
    1. Voûte MT,
    2. Hendriks JM,
    3. van Laanen JH, et al

    . Radial force measurements in carotid stents: influence of stent design and length of the lesion. J Vasc Interv Radiol 2011;22:661–66 doi:10.1016/j.jvir.2011.01.450 pmid:21514520

    CrossRefPubMed
14. 14.↵
    1. Barnett HJ,
    2. Taylor DW,
    3. Eliasziw M, et al

    . Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339:1415–25 doi:10.1056/NEJM199811123392002 pmid:9811916

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Kurosaki Y,
    2. Yoshida K,
    3. Fukumitsu R, et al

    . Carotid artery plaque assessment using quantitative expansive remodeling evaluation and MRI plaque signal intensity. J Neursurg 2016;124:736–42 doi:10.3171/2015.2.JNS142783 pmid:26361279

    CrossRefPubMed
16. 16.↵
    1. Iwata T,
    2. Mori T,
    3. Tajiri H, et al

    . Predictors of hyperperfusion syndrome before and immediately after carotid artery stenting in single-photon emission computed tomography and transcranial color-coded real-time sonography studies. Neurosurgery 2011;68:649–55 doi:10.1227/NEU.0b013e3182077ed8 pmid:21311294

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Iwata T,
    2. Mori T,
    3. Miyazaki Y, et al

    . Global oxygen extraction fraction by blood sampling to anticipate cerebral hyperperfusion phenomenon after carotid artery stenting. Neurosurgery 2014;75:546–51 doi:10.1227/NEU.0000000000000485 pmid:24991711

    CrossRefPubMed
18. 18.↵
    1. Iwata T,
    2. Mori T,
    3. Tanno Y, et al

    . Measurement of oxygen extraction fraction by blood sampling to estimate severe cerebral hemodynamic failure and anticipate cerebral hyperperfusion syndrome following carotid artery stenting. J Neurointerv Surg 2018;10:1063–66 doi:10.1136/neurintsurg-2018-013748 pmid:29511115

    Abstract/FREE Full Text
19. 19.↵
    1. Iwata T,
    2. Mori T,
    3. Miyazaki Y, et al

    . Initial experience of a novel sheath guide for transbrachial carotid artery stenting: technical note. J Neurointerv Surg 2013;5(Suppl 1):i77–80 doi:10.1136/neurintsurg-2012-010506 pmid:23255821

    Abstract/FREE Full Text
20. 20.↵
    1. Yoshimura S,
    2. Yamada K,
    3. Kawasaki M, et al

    . High-intensity signal on time-of-flight magnetic resonance angiography indicates carotid plaques at high risk for cerebral embolism during stenting. Stroke 2011;42:3132–37 doi:10.1161/STROKEAHA.111.615708 pmid:21868725

    Abstract/FREE Full Text
21. 21.↵
    1. Bussière M,
    2. Pelz DM,
    3. Kalapos P, et al

    . Results using a self-expanding stent alone in the treatment of severe symptomatic carotid bifurcation stenosis. J Neurosurg 2008;109:454–60 doi:10.3171/JNS/2008/109/9/0454 pmid:18759576

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Kimura T,
    2. Yokoi H,
    3. Nakagawa Y, et al

    . Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 1996;334:561–66 doi:10.1056/NEJM199602293340903 pmid:8569823

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Mori T,
    2. Kazita K,
    3. Chokyu K, et al

    . Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000;21:249–54 pmid:10696004

    Abstract/FREE Full Text
24. 24.↵
    1. Kaku Y,
    2. Yoshimura S,
    3. Kokuzawa J

    . Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement. AJNR Am J Neuroradiol 2004;25:1403–08 pmid:15466341

    Abstract/FREE Full Text
25. 25.↵
    1. Takigawa T,
    2. Matsumaru Y,
    3. Hayakawa M, et al

    . Cilostazol reduces restenosis after carotid artery stenting. J Vasc Surg 2010;51:51–56 doi:10.1016/j.jvs.2009.08.040 pmid:19879096

    CrossRefPubMed
26. 26.↵
    1. Miyazaki Y,
    2. Mori T,
    3. Iwata T, et al

    . Continuous daily use of Cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions. J Neurointerv Surg 2016;8:471–75 doi:10.1136/neurintsurg-2014-011565 pmid:25829365

    Abstract/FREE Full Text
27. 27.↵
    1. Nakazaki M,
    2. Mori T,
    3. Iwata T, et al

    . Retrospective analysis of the effectiveness of yokukansan (Japanese herbal medicine (TJ-54) in the treatment of delirium following acute stroke [in Japanese]. No Shinkei Geka 2013;41:765–71 pmid:24018783

    PubMed
28. 28.↵
    1. Uchida K,
    2. Yoshimura S,
    3. Shirakawa M, et al

    . Experience of staged angioplasty to avoid hyperperfusion syndrome for carotid artery stenosis. Neurol Med Chir (Tokyo) 2015;55:824–29 doi:10.2176/nmc.oa.2015-0102 pmid:26447098

    CrossRefPubMed
29. 29.↵
    1. Ogata A,
    2. Sonobe M,
    3. Kato N, et al

    . Carotid artery stenting without post-stenting balloon dilatation. J Neurointerv Surg 2014;6:517–20 doi:10.1136/neurintsurg-2013-010873 pmid:24014467

    Abstract/FREE Full Text
30. 30.↵
    1. Baldi S,
    2. Zander T,
    3. Rabellino M, et al

    . Carotid artery stenting without angioplasty and cerebral protection: a single-center experience with up to 7 years’ follow-up. AJNR Am J Neuroradiol 2011;32:759–63 doi:10.3174/ajnr.A2375 pmid:21349967

    Abstract/FREE Full Text